Phenotypic Analysis of Peanut-Responsive T Cells at Baseline in Subjects Enrolled in CoFAR6, a Randomized Placebo-Controlled Epicutaneous Immunotherapy (EPIT) Trial for the Treatment of Peanut Allergy

Methods Baseline blood samples were obtained from challenge-confirmed peanut-allergic subjects (4-25 years) enrolled in CoFAR6 (n=75), and from healthy controls (n=8).

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2015-02, Vol.135 (2), p.AB226-AB226
Main Authors: Chiang, David, MS, Burks, A. Wesley, MD, Davidson, Wendy, PhD, Dawson, Peter, PhD, Grishin, Alexander, PhD, Henning, Alice, MS, Jones, Stacie M., MD, Leung, Donald Y.M., MD, PhD, FAAAAI, Lindblad, Robert W., MD, Liu, Andrew H., MD, FAAAAI, Scurlock, Amy M., MD, Sicherer, Scott H., MD, Vickery, Brian P., MD, Wood, Robert A., MD, Sampson, Hugh A., MD, Berin, Cecilia, PhD
Format: Article
Language:English
Subjects:
Allergies
Allergy and Immunology
Food allergies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods Baseline blood samples were obtained from challenge-confirmed peanut-allergic subjects (4-25 years) enrolled in CoFAR6 (n=75), and from healthy controls (n=8).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2014.12.1673